ProCE Banner Activity

CE / CME

Challenging Cases in HIV Management

Multimedia
Led by Daniel R. Kuritzkes, MD, a panel of experts discusses their personal approach to the management of challenging HIV case patients.

Pharmacists : 1.00 contact {hour} ({0.1} CEUs)

Physicians : maximum of 1.00 AMA PRA Category 1 {Credit}

Registered Nurses : 1.00 Nursing contact {hour}

Released: July 08, 2016

Expiration: July 07, 2017

No longer available for credit.

Share

Faculty

Joel E. Gallant

Joel E. Gallant, MD, MPH

Professor of Medicine & Epidemiology
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Kathleen E. Squires

Kathleen E. Squires, MD

Professor of Medicine
Director, Division of Infectious Diseases
Jefferson Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania

Charles B. Hicks

Charles B. Hicks, MD

Professor of Medicine
Duke University Medical Center
Durham, North Carolina

Daniel R. Kuritzkes

Daniel R. Kuritzkes, 医学博士

科长,传染病科
布莱根妇女医院
Harriet Ryan Albee 医学教授
哈佛医学院
波士顿,马萨诸塞州

Babafemi Taiwo

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

AbbVie

Bristol Myers Squibb

Gilead

Janssen

Merck Human Health HIV

ViiV Healthcare

Target Audience

This activity is intended for HIV specialists, infectious diseases clinicians, hepatologists, gastroenterologists, registered nurses, pharmacists, and other healthcare professionals involved in the care of patients with HIV infection and/or chronic hepatitis C.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply the results of recent clinical studies on the timing and choice of first-line antiretroviral therapy and the use of newer antiretroviral agents in switch strategies for HIV-infected patients
  • Effectively prevent or manage drug–drug interactions, adverse events, and other complications associated with HIV, antiretroviral therapy, and comorbidities
  • Apply evidence-based strategies for the use of antiretroviral therapy as prevention
  • Pharmacists will be better able to provide accurate and appropriate counsel as part of the treatment team
  • Nurses will be better able to provide appropriate care and counsel for patients and their families

Program Director Disclosure

Program Director

Joel E. Gallant, MD, MPH

Professor of Medicine & Epidemiology
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Joel E. Gallant, MD, MPH, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV and funds for research support from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Sangamo, and ViiV.

Kathleen E. Squires, MD

Professor of Medicine
Director, Division of Infectious Diseases
Jefferson Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania

Kathleen E. Squires, MD, has disclosed that she has served on advisory boards for scientific purposes for Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV and for marketing purposes for Gilead Sciences and Janssen and has received funds for research support(paid to Thomas Jefferson University) from Gilead Sciences.

Faculty Disclosure

Primary Author

Charles B. Hicks, MD

Professor of Medicine
Duke University Medical Center
Durham, North Carolina

Charles B. Hicks, MD, has disclosed that he has received consulting fees from Gilead Sciences, Janssen Virology, Merck, and ViiV; has served on an international data monitoring committee for MedImmune; and has received royalties from UpToDate.

Daniel R. Kuritzkes, 医学博士

科长,传染病科
布莱根妇女医院
Harriet Ryan Albee 医学教授
哈佛医学院
波士顿,马萨诸塞州

Daniel R. Kuritzkes, MD, has disclosed that he has received consulting fees from Gilead Sciences, Merck, and ViiV; fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speaker bureaus) from Merck; and funds for research support from Gilead Sciences.

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS, has disclosed that he has received consulting fees from GlaxoSmithKline and ViiV and funds for research support from ViiV.

Staff Disclosure

Staff

Rachael M. Andrie, PhD

Clinical Editor

Rachael M. Andrie, PhD, has no real or apparent conflicts of interest to report.

Jennifer M. Blanchette, Ph.D.

Clinical Editor
Clinical Care Options, LLC

Jennifer Blanchette, PhD, has no real or apparent conflicts of interest to report.

Megan K. Murphy, PhD

Scientific Director

Megan Murphy, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.


Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.


Credit Designation

1.0 contact hour may be earned for successful completion of this activity.

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Credit Designation

This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Activity #0797-9999-16-034-H04-P. This program is designated for up to 1.0 contact hour (0.1 CEU) of continuing pharmacy education credit.


Type of Activity

Knowledge


Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from July 08, 2016, through July 07, 2017:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ competence in addressing the most important and most current challenges in HIV and HCV management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic.